BridgeMD
New treatment option for Incontinence, Urinary
Official title Testing the Protective and Caring Effect of a Water-in-oil Formulation in Patients Suffering From Urinary and/or Fecal Incontinence and Requiring Incontinence Care Products
ClinicalTrials.gov ID: NCT06924502
What this study is testing
- What it's testing
- The aim of this study is to test the protecting and caring effect of a protective balm on patients suffering from urinary and/or fecal incontinence and need incontinence care products.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 70 and older
You may be able to join if
- Patient is capable of understanding the information given to them and providing informed consent
- 70 years of age and older
- Patients with incontinence (fecal and/or urinary), requiring incontinence protection material
- Skin type on Fitzpatrick scale: Between I to IV
You likely can't join if
- Current cancer treatment such as chemotherapy, irradiation
- Documented allergies to skin care and / or skin cleansing products
- Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
- Incontinence-associated dermatitis (IAD) stage \>1a
- Active skin disease at the test area
- Any topical medication at the test area within the last 3 days prior to the start of the study and / or hroughout te entire course of the study
See the full eligibility criteria
- Patient is capable of understanding the information given to them and providing informed consent
- 70 years of age and older
- Patients with incontinence (fecal and/or urinary), requiring incontinence protection material
- Skin type on Fitzpatrick scale: Between I to IV
- Current cancer treatment such as chemotherapy, irradiation
- Documented allergies to skin care and / or skin cleansing products
- Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
- Incontinence-associated dermatitis (IAD) stage \>1a
- Active skin disease at the test area
- Any topical medication at the test area within the last 3 days prior to the start of the study and / or hroughout te entire course of the study
- Mini-Mental-Status-Test (MMST) \< 20
The study team makes the final eligibility decision.
Where it's taking place
- Dortmund, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 70 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dortmund, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.